Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Clinical trial NCT00124189 · COMPLETED

Trial details

NCT number: NCT00124189
Sponsor: Geron Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphoproliferative Diseases

Start date: 2005-07-01
Primary completion: 2013-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.